Filter Results :

Your search for Biopharmaceutical returned 95 reports

Sort by


Opportunity in the Indian Biopharmaceuticals Market - 2015: Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

06 Mar 2015  |  Published by:  Feedback Consulting
This report provides an insight into the Opportunity in the Indian Biopharmaceuticals current market scenario, structure and practices.In depth market scenario includes;- Indian Biopharmaceuticals Market Size- Market share of key players – Top companies- Market size for Vaccines- Market size for Di...

$ 6,000.00

Read More

Navidea Biopharmaceuticals, Inc. (NAVB) - Medical Equipment - Deals and Alliances Profile

13 Feb 2015  |  Published by:  GlobalData
SummaryNavidea Biopharmaceuticals, Inc. (Navidea) is a biopharmaceutical company focused on the development and commercialization of radiopharmaceutical agents and precision diagnostics. The company's pipeline products include Lymphoseek, a radiopharmaceutical agent for lymph node mapping for the di...

$ 250.00

Read More

Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), And Geography - Forecast Till 2019

11 Feb 2015  |  Published by:  MarketsandMarkets
Report Description The biocatalysts market was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to grow at a CAGR of 5.5% from 2014 to 2019. The high growth is forecasted...

$ 4,650.00

Read More

Ipsen Biopharmaceuticals, Inc. - Strategic SWOT Analysis Review

03 Feb 2015  |  Published by:  GlobalData
Ipsen Biopharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod...

$ 125.00

Read More

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical products in the areas of unmet clinical needs. The company has three product candidates such as ...

$ 300.00

Read More

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. Its pharmaceuticals protect and repair tissue and organ damage caused by disease, trauma or othe...

$ 300.00

Read More

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company. The company operates through Chinese Medicines and Chemical Medicines segment, Investment Segment, and Other Segments. Its Chinese medicines and chemical medicines segment manufactures, sells and distributes modernized Chinese...

$ 300.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and P...

$ 300.00

Read More

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

01 Feb 2015  |  Published by:  GlobalData
SummaryKythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline product include ATX-101. Kythera’s ATX-101 is an injectable drug, which is currently in late stag...

$ 300.00

Read More

PlasmaTech Biopharmaceuticals, Inc. (PTBI) - Medical Equipment - Deals and Alliances Profile

20 Jan 2015  |  Published by:  GlobalData
SummaryPlasmaTech Biopharmaceuticals, Inc., (PlasmaTech) is a biopharmaceutical company. It develops novel medicines for the treatment of cancer and supportive care of cancer patients. The company’s product MuGard for the management of patients with mucositis is approved in the US, EU, China and Sou...

$ 250.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Medical Equipment - Deals and Alliances Profile

20 Jan 2015  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and P...

$ 250.00

Read More

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

10 Dec 2014  |  Published by:  Global Markets Direct
Summary'RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the RegeneRx Biopharmaceuticals, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of RegeneRx Biop...

$ 1,500.00

Read More

China Biopharmaceuticals Mfg. Industry Data Report

08 Dec 2014  |  Published by:  Beijing Zeefer Consulting Ltd
This data report provides key statistics and concise analysis on biopharmaceuticals mfg. industry in China. It presents an overview on biopharmaceuticals mfg. industry's overall performance for the year 2011 to 2013, and reveals differences in various regions of Mainland China in terms of biopharmac...

$ 580.00

Read More

XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014

30 Nov 2014  |  Published by:  Global Markets Direct
Summary‘XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2014’, provides an overview of the XTL Biopharmaceuticals Ltd.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of XTL Biopharmaceuticals Lt...

$ 1,500.00

Read More

Transposagen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryTransposagen Biopharmaceuticals, Inc. (Transposagen) is a biotechnology company. The company provides animal models, cell lines, stem cells and research tools and technologies for drug discovery and development research. Its gene modification tools include Footprint-Free Gene Editing, XTN TAL...

$ 250.00

Read More
Total 95 records.